SLC25A29 CRISPR/Cas9 KO Plasmid (h): sc-406645
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- SLC25A29 CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
- gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the SLC25A29 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
- The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SLC25A29 CRISPR/Cas9 KO Plasmid (h) | sc-406645 | 20 µg | $397.00 |
Overview
SLC25A29 (solute carrier family 25 member 29) encodes a mitochondrial inner membrane carrier implicated in transporting basic amino acids, particularly arginine, into the mitochondrial matrix to support metabolic flux through the urea cycle–linked arginine/ornithine network and nitric oxide–related metabolism. By shaping intramitochondrial amino acid availability, SLC25A29 can influence mitochondrial respiration, redox balance, and biosynthetic pathways that depend on one-carbon and nitrogen handling. Altered expression or activity of mitochondrial SLC25 carriers is frequently associated with metabolic rewiring and mitochondrial dysfunction observed across diverse disease contexts, making SLC25A29 a useful target for mechanistic studies of mitochondrial amino acid transport. Research on SLC25A29 also informs how mitochondrial substrate partitioning impacts cellular stress responses and energy homeostasis.
SLC25A29 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SLC25A29 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SLC25A29 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SLC25A29 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SLC25A29 protein expression.
This CRISPR knockout system enables efficient generation of SLC25A29-deficient cell models for investigation of SLC25A29 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
Key Features
- sgRNAs targeting SLC25A29 exon(s) critical for SLC25A29 function
- Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
- GFP reporter for identification of transfected cells
- Pool of plasmids targeting multiple SLC25A29 genomic sites to improve knockout efficiency
- Compatible with delivery by transfection
Design Variants
CRISPRs +/- HDRs
- gRNAs encoded by SLC25A29 CRISPR/Cas9 KO Plasmid (h) and SLC25A29 CRISPR/Cas9 KO Plasmid (h2) target distinct sites within the SLC25A29 locus. One or both targeting designs may be available. See Related Products for availability.
- HDR donor constructs encoded by SLC25A29 HDR Plasmid (h) and SLC25A29 HDR Plasmid (h2) contain a puromycin resistance cassette and an RFP reporter flanked by SLC25A29 homology arms to support homology-directed repair at defined SLC25A29 target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.